Masked hypertension associates with left ventricular hypertrophy in children with CKD

Mark Mitsnefes1, Joseph Flynn, Silvia Cohn

  • 1Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA. mark.mitsnefes@cchmc.org

Insights

Hypertension, including masked hypertension, significantly increases the risk of left ventricular hypertrophy (LVH) in children with chronic kidney disease (CKD). Standard blood pressure checks are insufficient; early screening with echocardiography and ambulatory BP monitoring is crucial for assessing cardiovascular risk.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Research
  • Hypertension Studies

Background:

  • Left ventricular hypertrophy (LVH) is a known cardiovascular risk factor in adults, often linked to hypertension.
  • The role of hypertension in the development of LVH in pediatric chronic kidney disease (CKD) populations is not well-established.

Purpose of the Study:

  • To assess left ventricular mass and identify factors associated with LVH in children stages 2-4 CKD.
  • To evaluate the prevalence of masked and confirmed hypertension in this cohort.

Main Methods:

  • Cross-sectional analysis of 366 children from the CKiD study with baseline echocardiography.
  • Ambulatory blood pressure (BP) monitoring was performed on 226 children.
  • BP data combined with casual BP measurements for hypertension classification.

Main Results:

  • 17% of children exhibited LVH; 38% had masked hypertension, and 18% had confirmed hypertension.
  • LVH was significantly more prevalent in children with masked (20%) or confirmed (34%) hypertension compared to normotensive children (8%).
  • Masked and confirmed hypertension were the strongest independent predictors of LVH (OR 4.1 and 4.3, respectively).

Conclusions:

  • Casual BP measurements are inadequate for predicting LVH in pediatric CKD.
  • The high prevalence of masked hypertension underscores the need for ambulatory BP monitoring.
  • Early echocardiography and ambulatory BP monitoring are recommended for cardiovascular risk assessment in children with CKD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...